Written answers
Wednesday, 10 March 2021
Department of Health
Medicinal Products
Rose Conway-Walsh (Mayo, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
962. To ask the Minister for Health the status of the inquiry into the historical licensing of sodium valproate which was announced in November 2020; if the terms of reference have been agreed; and if he will make a statement on the matter. [13444/21]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Details of the proposed inquiry into the historical licensing and use of sodium valproate in Ireland are being considered by officials within the Department of Health.
Rose Conway-Walsh (Mayo, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
963. To ask the Minister for Health if he plans to establish a valproate stakeholder group consisting of State bodies, representative and patient groups to improve the co-ordination of risk minimisation measures associated with the ongoing use of sodium valproate in women of child-bearing age; and if he will make a statement on the matter. [13445/21]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The establishment of a valproate stakeholder group as described by the Deputy is being considered by officials as part of the Department's overall response to issues relating to sodium valproate.
No comments